Ticker
LGVNCompany Name
LONGEVERON INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 631K | 30.44% | $ 2.07M |
3/31/2025 | $ 666K | 29.93% | $ 2.23M |
12/31/2024 | $ 655K | 27.38% | $ 2.39M |
9/30/2024 | $ 806K | 43.52% | $ 1.85M |
6/30/2024 | $ 379K | 30.84% | $ 1.23M |
3/31/2024 | $ 275K | 28.12% | $ 978K |
12/31/2023 | $ 301K | 42.45% | $ 709K |
9/30/2023 | $ 203K | 26.47% | $ 767K |
6/30/2023 | $ 578K | 65.53% | $ 882K |
3/31/2023 | $ 564K | 49.87% | $ 1.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / Revenues
(=) CapEx %
CapEx % for LONGEVERON INC is calculated as follows: CapEx [ $ 37.57K ] / Revenues [ $ 5.64M ]
(=) CapEx % [ 0.67% ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 2.85K |
---|---|
min | 0% |
max | 15.04% |
average | 3.47% |
median | 2.43% |
std | 3.28% |